Core C – Immunophenotyping Core
- Institution
- MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC
- Principal investigator
- Jian Ouyang
- Funding
- $200K
- Duration
- 2021–2026
Moonbase score
Still being scored
Abstract
SUMMARY: CORE C Cachexia is a wasting syndrome that significantly contributes to the morbidity and mortality of cancer patients, especially those diagnosed with pancreatic ductal adenocarcinoma (PDAC). The overarching hypothesis of this P01 project is that the NF-κB/IL-6/STAT3 signaling axis acts as a central regulator of the macroenvironment in PDAC-induced cachexia, encompassing tumor, skeletal muscle and adipose tissues. Three projects in this P01 focus on specific components of this signaling axis integrating on the use of mouse models and patient samples. The role of the Immunophenotyping Core will be to support molecular and histological studies in the projects requiring next generation single cell sequencing (scRNA-seq) and multispectral imaging. In addition, the Immunophenotyping Core will use deep learning methods to perform the quantitation of multiplex images of immune cells to assess the function of the NF-κB/IL-6/STAT3 signaling axis in the progression of PDAC and wasting of muscle and adipose tissues in cachexia. The two specific aims of the Immunophenotyping core is to 1) Utilize multiplex immunofluorescence panels and multispectral imaging to evaluate how the NF-κB/STAT3/IL- 6 signaling axis regulates the immune architecture contributing to PDAC tumor progression and muscle and adipose wasting; and 2) Perform single-cell RNA-sequencing (scRNA-seq) to reveal functional pathways regulated by the NF-κB/STAT3/IL-6 signaling axis in the macroenvironment of murine models of PDAC-induced cachexia.
LOADING MOONBASE SCORE
Questions for MEDICAL UNIVERSITY OF SOUTH CAROLINA
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Medical University of South CarolinaNot yet scored
Translational Science Laboratory Shared Resource
Jian Ouyang · $69K · 2009–2029
- NIH · Medical University of South Carolina67
Addressing Rural Cancer Disparities via Proactive Smoking Cessation Treatment within Primary Care: A Hybrid Type 1 Effectiveness-Implementation Trial of a Scalable Smoking Cessation Electronic Visit
Jennifer Renee Dahne · $924K · 2022–2028
- NIH · Medical University of South Carolina48
Reversing inflammatory macrophage activation as treatment for neonatal intraventricular hemorrhage and hydrocephalus
Brandon A Miller · $175K · 2024–2025